Pfizer coronavirus vaccine exceeds FDA standard
As the world anxiously waits for any positive news about a coronavirus vaccine, Pfizer announced Monday that its coronavirus vaccine is more than 90 percent effective.
As the world anxiously waits for any positive news about a coronavirus vaccine, Pfizer announced Monday that its coronavirus vaccine is more than 90 percent effective.
Pfizer coronavirus vaccine exceeds expectations
As the world anxiously waits for any positive news about a coronavirus vaccine, Pfizer announced Monday that its coronavirus vaccine is more than 90 percent effective.
As the world anxiously waits for any positive news about a coronavirus vaccine, Pfizer announced Monday that its coronavirus vaccine is more than 90 percent effective.
COVID-19 vaccine: Who will get the first doses?
Scientists vary in their recommendations over who should get the first doses of the COVID-19 vaccine.
Scientists vary in their recommendations over who should get the first doses of the COVID-19 vaccine.
AstraZeneca plans to deliver vaccine trial data by year's end
AstraZeneca hopes to show its COVID-19 vaccine is effective by the end of this year and is ramping up manufacturing so it can supply hundreds of millions of doses in January, Chief Executive Pascal Soriot said Thursday.
AstraZeneca hopes to show its COVID-19 vaccine is effective by the end of this year and is ramping up manufacturing so it can supply hundreds of millions of doses in January, Chief Executive Pascal Soriot said Thursday.
Fauci estimates COVID-19 vaccine won’t be available until January 2021 or later
The nation’s top infectious disease expert doesn’t anticipate a COVID-19 vaccine to be available in the U.S. until at least January 2021, if not later, due to several regulatory hurdles still ahead.
The nation’s top infectious disease expert doesn’t anticipate a COVID-19 vaccine to be available in the U.S. until at least January 2021, if not later, due to several regulatory hurdles still ahead.
Maryland Gov. Larry Hogan says vaccination plan prioritizes frontline workers
Maryland has finally caught up with neighboring D.C. and Virginia, and now has a COVID-19 vaccination plan the state can implement before a vaccine is available for distribution.
Maryland has finally caught up with neighboring D.C. and Virginia, and now has a COVID-19 vaccination plan the state can implement before a vaccine is available for distribution.
DC will prioritize want over vulnerability for COVID-19 vaccine distribution
In September, the CDC issued a directive telling jurisdictions to prepare for having a COVID-19 vaccine in place by early November – and both the District and Virginia are already getting ready.
In September, the CDC issued a directive telling jurisdictions to prepare for having a COVID-19 vaccine in place by early November – and both the District and Virginia are already getting ready.
Eli Lilly pauses COVID-19 antibody drug trial over potential safety concerns
The Eli Lilly drug is similar to one that President Donald Trump received from Regeneron Pharmaceuticals.
The Eli Lilly drug is similar to one that President Donald Trump received from Regeneron Pharmaceuticals.
2nd coronavirus vaccine trial paused over unexplained illness
The pause is at least the second such hold to occur among several vaccines that have reached large-scale final tests in the U.S.
The pause is at least the second such hold to occur among several vaccines that have reached large-scale final tests in the U.S.